ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8,301 | 57.10098 | 1 | female | 0 | 4 | 1,000 | Lung Cancer | Cancer | 1 | 11 | $11-$25k | 0 | 2,784 | 1,590.1895 | 914.3999 | 13 | white | 14.599609 | 13 | 0.767944 | 0.519897 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 4 | 104 | 10.599609 | 69 | 24 | 38.09375 | null | null | 0.199982 | 1.099854 | 132 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,302 | 83.19495 | 1 | female | 0 | 3 | 89 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 1,538 | 1,025.7471 | 985.06982 | 15 | white | 24.597656 | 27 | 0.465942 | 0.15097 | 1 | 1 | 0 | metastatic | 0.6 | 0.4 | dnr after sadm | 1 | 74 | 12.298828 | 77 | 24 | 36.69531 | null | 2.699707 | 0.599976 | 0.899902 | 134 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.966797 |
8,303 | 70.82495 | 1 | female | 0 | 8 | 1,135 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | null | 26 | 5,587 | 3,600.9805 | 3,241.47852 | 9.5 | white | 20.597656 | 38 | 0.762939 | 0.622925 | 1 | 0 | 0 | no | 0.95 | 0.85 | dnr after sadm | 1 | 77 | 17.398438 | 71 | 28 | 36.19531 | 236 | null | null | 1.5 | 134 | 7.379883 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,304 | 69.15295 | 0 | male | 0 | 8 | 1,440 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,159 | 6,785.2852 | 6,877.88672 | 10.5 | white | 18 | 29 | 0.843994 | 0.743896 | 4 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 8 | 102 | 11 | 66 | 24 | 35.69531 | 224 | 3.899902 | 0.899902 | 1.199951 | 131 | 7.239258 | null | null | null | null | null | null | 3.24707 |
8,305 | 73.08398 | 1 | male | 0 | 12 | 76 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | under $11k | 0 | 14,307 | 10,014.0859 | 10,173.5391 | 19 | white | 17.898438 | 26 | 0.822998 | 0.762939 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 12 | 75 | 11.298828 | 70 | 24 | 36.39844 | 268 | 3.899902 | 1.099854 | 1.399902 | 137 | 7.389648 | null | null | null | null | 0 | null | 0 |
8,306 | 65.396 | 1 | male | 0 | 12 | 147 | CHF | COPD/CHF/Cirrhosis | 7 | 11 | under $11k | 0 | 7,884 | 5,273.1055 | 6,633.85938 | 6 | white | 15.298828 | 46 | 0.901978 | 0.835938 | 1 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 12 | 79 | 9.599609 | 73 | 28 | 36.39844 | null | 4.599609 | 0.799927 | 3 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,307 | 75.93695 | 1 | male | 1 | 17 | 17 | CHF | COPD/CHF/Cirrhosis | 5 | 6 | $11-$25k | 0 | 24,965 | 16,674.9531 | 16,149.3281 | 20.333328 | white | 26.398438 | 35 | 0.727905 | 0.574951 | 1 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 3 | 70 | 12.798828 | 110 | 40 | 37.59375 | 210 | 2.899902 | 0.799927 | 1.399902 | 136 | 7.449219 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
8,308 | 54.34399 | 1 | male | 0 | 3 | 207 | Lung Cancer | Cancer | 2 | 11 | >$50k | 0 | 1,509 | 1,049.8047 | 1,218.58984 | 5 | white | 18.597656 | 16 | 0.700928 | 0.414978 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | no dnr | 3 | 81 | null | 96 | 28 | 35.79688 | null | null | null | null | 140 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,309 | 73.34698 | 0 | female | 0 | 11 | 1,439 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 18,090 | 11,908.6641 | 12,040.9531 | 20.5 | white | 22 | 22 | 0.765991 | 0.690918 | 6 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 11 | 120 | 23.398438 | 60 | 24 | 36.69531 | 145 | 3.899902 | 0.399963 | 1 | 141 | 7.429688 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
8,310 | 77.43195 | 1 | male | 0 | 12 | 432 | Lung Cancer | Cancer | 1 | null | null | 0 | 13,719 | null | null | 6.5 | white | 8.699219 | 17 | 0.820923 | 0.612915 | 1 | 0 | 0 | metastatic | 0.99 | 0.95 | no dnr | 12 | 113 | 12.599609 | 76 | 20 | 36.39844 | null | 4.099609 | 0.599976 | 1.199951 | 141 | null | null | null | null | null | null | null | 2.520508 |
8,311 | 76.73096 | 1 | female | 1 | 36 | 36 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | $11-$25k | 37 | 83,635 | 61,648.1562 | 61,913.9062 | 24.75 | white | 39.59375 | 58 | 0.112991 | 0.047997 | 12 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 36 | 53 | 16.398438 | 134 | 12 | 35.59375 | 152 | 2.399902 | 1.799805 | 2.599609 | 146 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,312 | 61.45398 | 1 | male | 1 | 35 | 35 | MOSF w/Malig | ARF/MOSF | 0 | 12 | under $11k | 9 | 154,093 | 101,554.438 | 115,426.5 | 43.5 | white | 29.398438 | 51 | 0.416992 | 0.296997 | 19 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 7 | 73 | 0.199982 | 110 | 30 | 39.5 | 253.3125 | null | null | 1.399902 | 139 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 1.907715 |
8,313 | 50.133 | 1 | male | 0 | 15 | 22 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | under $11k | 0 | 28,895 | 20,353.9219 | 20,749.3125 | 28.666656 | white | 22.796875 | 40 | 0.803955 | 0.68396 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 15 | 67 | 11.699219 | 134 | 10 | 39.59375 | 233.3125 | 2.5 | 1.099854 | 0.899902 | 138 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.691895 |
8,314 | 85.96295 | 1 | female | 0 | 6 | 1,328 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 6,391 | 4,357.6367 | 4,165.54688 | 20 | white | 26.398438 | 36 | 0.67688 | 0.582886 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 6 | 79 | 23.796875 | 116 | 32 | 38.69531 | 186.65625 | 4.099609 | 0.199982 | 0.699951 | 131 | 7.489258 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,315 | 69.47797 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 3 | 12 | under $11k | 0 | 25,801 | 16,894.9688 | 19,424.7656 | 40.5 | white | 41.5 | 54 | 0.098999 | 0.040993 | 4 | 0 | 0 | metastatic | 0.1 | 0.001 | no dnr | 7 | 105 | 16.296875 | 120 | 34 | 38.19531 | 86.25 | null | null | 2.699707 | 124 | 7.509766 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
8,316 | 70.836 | 1 | male | 0 | 4 | 122 | Lung Cancer | Cancer | 1 | 7 | under $11k | 0 | 3,294 | 1,952.7148 | 1,427.48926 | 7 | white | 9 | 20 | 0.826904 | 0.623901 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 119 | 5.5 | 98 | 24 | 36.5 | null | 4.099609 | 0.399963 | 1.099854 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.772217 |
8,317 | 70.86395 | 1 | male | 0 | 6 | 982 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 5,788 | 4,110.832 | 3,670.69922 | 20 | white | 21.898438 | 32 | 0.819946 | 0.707886 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 1 | 53 | 10.099609 | 56 | 12 | 38.39844 | null | 2.699707 | 1.799805 | 1 | 133 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
8,318 | 80.58295 | 1 | male | 1 | 14 | 14 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 22,019 | 14,455.2656 | 14,269.1328 | 29 | white | 21.898438 | 32 | 0.747925 | 0.602905 | 1 | 0 | 0 | no | 0.5 | 0.1 | dnr after sadm | 4 | 70 | 8.599609 | 77 | 30 | 38.29688 | 137.5 | 3.099609 | 0.5 | 0.699951 | 138 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 3.407227 |
8,319 | 53.81198 | 1 | male | 0 | 8 | 173 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 4,288 | 3,318.6133 | 3,390.82812 | 2 | white | 15.298828 | 11 | 0.762939 | 0.511963 | 1 | 0 | 0 | metastatic | null | null | no dnr | 8 | 113 | 9.099609 | 56 | 20 | 36.19531 | null | 3.699707 | 0.299988 | 1 | 133 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,320 | 77.58197 | 0 | female | 0 | 6 | 1,421 | COPD | COPD/CHF/Cirrhosis | 0 | null | null | 9 | 8,004 | 5,128.5703 | 5,097.39844 | 10 | white | 16.898438 | 32 | 0.806885 | 0.687988 | 2 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 6 | 115 | null | 74 | 22 | 36.29688 | 184 | null | null | null | 140 | 7.289062 | null | null | null | null | null | null | 2.940918 |
8,321 | 54.689 | 0 | female | 0 | 7 | 1,422 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 0 | 6,362 | 4,323.1992 | 4,391.4375 | 17 | white | 26.699219 | 34 | 0.802979 | 0.737915 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 7 | 65 | 3.199707 | 72 | 24 | 36.19531 | null | 2.799805 | 0.299988 | 4.199219 | 135 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
8,322 | 66.00397 | 1 | male | 0 | 6 | 104 | Lung Cancer | Cancer | 2 | 8 | null | 0 | 5,387 | 3,580.7188 | 3,115.80859 | 13 | white | 21.097656 | 22 | 0.615967 | 0.300964 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 79 | 7.299805 | 130 | 24 | 38.5 | null | 3.799805 | 0.399963 | 1.099854 | 123 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
8,323 | 88.04395 | 1 | male | 0 | 5 | 100 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 9 | 2,461 | 1,665.71 | 1,532.65918 | 6 | white | 21.898438 | 34 | 0.718994 | 0.56189 | 1 | 1 | 1 | no | 0.25 | 0.25 | no dnr | 5 | 102 | null | 83 | 24 | 36 | null | null | 0.299988 | 2.699707 | 132 | null | null | null | null | 6 | 4 | no(M2 and SIP pres) | 4 |
8,324 | 66.32397 | 1 | male | 0 | 19 | 902 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 30,250 | 20,162.25 | 19,742.6562 | 17.333328 | white | 20.796875 | 39 | 0.709961 | 0.621948 | 5 | 1 | 0 | yes | 0.8 | 0.6 | no dnr | 19 | 67 | 8.298828 | 65 | 10 | 38.59375 | 85.70312 | 1.799805 | 0.299988 | 1.099854 | 134 | 7.439453 | null | null | null | null | 0 | null | 0 |
8,325 | 62.63699 | 1 | male | 0 | 6 | 423 | CHF | COPD/CHF/Cirrhosis | 1 | 11 | under $11k | 0 | 4,544 | 2,984.0488 | 3,243.36914 | 9 | white | 20.296875 | 30 | 0.86499 | 0.775879 | 1 | 1 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 75 | 8.5 | 60 | 20 | 36.59375 | 107.5 | 3.899902 | 0.699951 | 1.199951 | 136 | 7.389648 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
8,326 | 74.92096 | 1 | male | 0 | 5 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | $11-$25k | 41 | 28,116 | 18,203.4219 | 20,067.8438 | 44 | white | 34.09375 | 71 | 0.173981 | 0.087997 | 8 | 1 | 0 | yes | 0 | 0 | dnr after sadm | 2 | 67 | 0.399963 | 104 | 32 | 39.5 | 265.6875 | 3.199707 | 2 | 2.899902 | 141 | 7.439453 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
8,327 | 60.62097 | 1 | female | 0 | 14 | 36 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | >$50k | 0 | 42,474 | 27,756.9531 | 30,864.4219 | 23 | white | 25.097656 | 43 | 0.826904 | 0.718994 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 56 | 19.898438 | 160 | 32 | 36.69531 | 220 | 3.699707 | 0.399963 | 0.699951 | 139 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,328 | 62.86099 | 0 | male | 0 | 5 | 1,417 | CHF | COPD/CHF/Cirrhosis | 4 | 13 | $25-$50k | 0 | 3,150 | 2,122.1133 | 2,094.81836 | 6 | white | 9.599609 | 24 | 0.940918 | 0.898926 | 1 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 5 | 65 | 7.799805 | 79 | 24 | 36.09375 | 261.875 | 4.699219 | 0.799927 | 0.899902 | 133 | 7.469727 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,329 | 68.99695 | 1 | male | 0 | 6 | 1,124 | COPD | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 3,835 | 2,503.3379 | 2,893.29883 | 3 | white | 13.099609 | 19 | 0.908936 | 0.846924 | 1 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 6 | 80 | 6.599609 | 101 | 28 | 36.59375 | 307.375 | 4.799805 | 0.299988 | 0.5 | 138 | 7.379883 | null | null | null | null | null | no(M2 and SIP pres) | 2.216797 |
8,330 | 64.85394 | 0 | male | 0 | 9 | 1,410 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 6,961 | 4,712.75 | 4,549.83984 | 13.5 | white | 16.296875 | 39 | 0.897949 | 0.829956 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 132 | 6 | 148 | 28 | 36.09375 | 248.125 | 4.399414 | 0.5 | 1 | 143 | 7.339844 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
8,331 | 66.76495 | 0 | female | 0 | 6 | 1,411 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 7,166 | 4,621.0664 | 5,069.59766 | 22 | white | 19.898438 | 31 | 0.822998 | 0.710938 | 1 | 0 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 3 | 107 | 11.898438 | 126 | 24 | 36.5 | 300 | 3.599609 | 0.399963 | 0.899902 | 137 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,332 | 44.48199 | 0 | female | 0 | 13 | 1,410 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 15,664 | 10,359.6328 | 10,514.7656 | 18.5 | white | 29.898438 | 49 | 0.792969 | 0.724976 | 1 | 0 | 0 | no | null | null | no dnr | 13 | 110 | 19.199219 | 142 | 28 | 38.69531 | 173.46875 | 2.599609 | 0.399963 | 2.699707 | 138 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,333 | 54.40097 | 1 | female | 0 | 7 | 260 | COPD | COPD/CHF/Cirrhosis | 3 | 13 | $11-$25k | 0 | 7,488 | 5,050.7344 | 5,283.14844 | 13 | white | 16.5 | 25 | 0.92688 | 0.875977 | 1 | 0 | 0 | no | 0.65 | 0.6 | no dnr | 7 | 63 | 16.699219 | 107 | 24 | 36.39844 | 204 | 4.199219 | 0.199982 | 0.799927 | 140 | 7.479492 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
8,334 | 65.02899 | 0 | male | 0 | 19 | 1,409 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 9 | 56,325 | 35,421.8438 | 39,795.4688 | 27.666656 | white | 17.398438 | 34 | 0.873901 | 0.790894 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 19 | 113 | 9.099609 | 146 | 30 | 38.29688 | 202.03125 | 4.199219 | 0.599976 | 1.299805 | 134 | 7.469727 | null | null | null | null | null | null | 2.938965 |
8,335 | 81.48096 | 1 | female | 1 | 3 | 3 | Coma | Coma | 0 | 16 | null | 100 | 32,997 | 21,490.9688 | 27,210.6562 | 14 | white | 21.199219 | 32 | 0.056 | 0.028999 | 27 | 0 | 0 | no | null | null | dnr after sadm | 3 | 117 | null | 134 | 32 | 38.5 | 377.75 | 3.099609 | 0.699951 | 1.099854 | 131 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.612793 |
8,336 | 71.737 | 0 | male | 0 | 5 | 1,406 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 3,561 | 2,334.3106 | 1,967.94922 | 7 | white | 5.799805 | 14 | 0.862915 | 0.69397 | 1 | 0 | 0 | metastatic | 0.99 | 0.99 | no dnr | 5 | 110 | 7.299805 | 89 | 20 | 35.69531 | null | 4.399414 | 0.199982 | 1 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.791748 |
8,337 | 80.02197 | 1 | female | 0 | 3 | 350 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 1,665 | 1,115.0947 | 1,304.96973 | 18 | white | 17.5 | 33 | 0.844971 | 0.744995 | 1 | 1 | 1 | no | 0.85 | 0.7 | dnr after sadm | 1 | 73 | 4.199219 | 104 | 20 | 35.89844 | 314.25 | 4.099609 | 0.599976 | 1.699951 | 135 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 4.041992 |
8,338 | 93.41498 | 1 | female | 0 | 10 | 1,325 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 6,652 | 4,363.7539 | 3,876.33984 | 7.5 | white | 18.097656 | 17 | 0.787964 | 0.658936 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr before sadm | -1 | 85 | 17.898438 | 64 | 24 | 36.29688 | null | 3.399902 | 0.599976 | 0.899902 | 136 | null | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
8,339 | 57.952 | 1 | male | 0 | 7 | 211 | Lung Cancer | Cancer | 1 | 7 | $25-$50k | 0 | 3,660 | 2,429.7559 | 2,444.68945 | 9 | white | 10.5 | 16 | 0.826904 | 0.623901 | 1 | 0 | 0 | metastatic | 0.8 | 0.3 | no dnr | 7 | 63 | 8.599609 | 62 | 24 | 36.09375 | null | 4.099609 | 0.5 | 1.199951 | 133 | null | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
8,340 | 81.11395 | 1 | male | 0 | 50 | 818 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | $11-$25k | 26 | 91,897 | 61,603.1875 | 62,473.7188 | 40 | white | 30.199219 | 58 | 0.307983 | 0.195984 | 9 | 0 | 0 | yes | null | null | no dnr | 50 | 51 | null | 68 | 28 | 35.89844 | 242.84375 | null | null | 4.799805 | 135 | 7.279297 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,341 | 73.70294 | 0 | male | 0 | 10 | 1,401 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 6,145 | 3,975.1602 | 3,636.23828 | 6 | white | 20 | 27 | 0.821899 | 0.709961 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 10 | 75 | 14.798828 | 69 | 28 | 35.5 | 240 | null | null | 0.899902 | 138 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,342 | 64.07898 | 1 | female | 0 | 4 | 278 | Colon Cancer | Cancer | 1 | 14 | under $11k | 9 | 2,834 | 1,935.4111 | 1,768.78906 | 9 | white | 15.599609 | 14 | 0.816895 | 0.605957 | 1 | 0 | 0 | metastatic | 0.8 | 0.3 | no dnr | 4 | 76 | null | 93 | 16 | 36.29688 | null | null | null | null | 140 | null | null | null | null | null | 0 | null | 0 |
8,343 | 58.905 | 1 | female | 0 | 5 | 93 | Lung Cancer | Cancer | 2 | 15 | $25-$50k | 0 | 3,402 | 2,032.0908 | 1,692.66992 | 9 | white | 7.099609 | 12 | 0.86499 | 0.696899 | 1 | 0 | 0 | metastatic | 0.5 | 0.15 | no dnr | 5 | 121 | 17.796875 | 96 | 20 | 37.39844 | null | 4.299805 | 0.599976 | 1 | 139 | null | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,344 | 52.90097 | 1 | female | 0 | 6 | 1,379 | CHF | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 4,159 | 2,839.4883 | 2,726.63867 | 14 | white | 17.296875 | 16 | 0.912964 | 0.852905 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 6 | 109 | 9.298828 | 118 | 20 | 36.39844 | null | 3.799805 | 0.299988 | 1.199951 | 136 | null | null | null | null | null | null | null | 3.262695 |
8,345 | 71.05499 | 1 | female | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 2 | 14 | under $11k | 0 | 21,861 | 14,073.1797 | 13,974.7734 | 28 | white | 24.097656 | 39 | 0.687988 | 0.595947 | 1 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 3 | 55 | 14.798828 | 116 | 31 | 38.29688 | 296.625 | 2.799805 | 0.399963 | 1.299805 | 134 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.076172 |
8,346 | 76.28998 | 1 | male | 1 | 4 | 4 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 4,655 | 2,850.7129 | 2,189.58984 | 21 | white | 25.398438 | 58 | 0.46698 | 0.151978 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 69 | 0.899902 | 126 | 36 | 35.69531 | null | null | null | 0.899902 | 132 | null | null | null | null | null | null | <2 mo. follow-up | 2.731934 |
8,347 | 64.93097 | 0 | female | 0 | 43 | 1,393 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | under $11k | 0 | 85,693 | 57,021 | 59,819.8125 | 35.75 | white | 27.898438 | 39 | 0.745972 | 0.665894 | 1 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 43 | 74 | 24.296875 | 125 | 42 | 38.09375 | 148 | null | null | 0.799927 | 141 | 7.479492 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
8,348 | 73.74896 | 1 | female | 1 | 9 | 9 | Coma | Coma | 1 | null | under $11k | 44 | 21,303 | 14,874.0625 | 15,504.2734 | 29.5 | white | 27.699219 | 44 | 0.233978 | 0.168976 | 4 | 0 | 0 | no | 0.6 | 0.6 | dnr after sadm | 9 | 129 | 14.298828 | 114 | 40 | 36.5 | 166 | null | null | 1.5 | 139 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,349 | 35.11298 | 1 | female | 0 | 11 | 106 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 12,351 | 8,735.1953 | 9,415.82812 | 14.5 | white | 30.296875 | 33 | 0.523926 | 0.407959 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 11 | 45 | 1.699951 | 76 | 26 | 37.89844 | null | 3.699707 | 0.5 | 1.199951 | 138 | null | null | null | null | 5 | null | no(M2 and SIP pres) | 3.855299 |
8,350 | 88.52295 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 11,769 | 7,572.7656 | 6,856.42969 | 39 | white | 27.597656 | 41 | 0.563965 | 0.451965 | 1 | 0 | 0 | yes | 0.1 | 0.001 | no dnr | 6 | 106 | 29.796875 | 70 | 41 | 38 | 110.20312 | 2.899902 | 1.199951 | 1.399902 | 132 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,351 | 62.92999 | 0 | male | 0 | 14 | 1,391 | Coma | Coma | 1 | 12 | null | 0 | 32,123 | 21,794.6094 | 26,767.9062 | 43.666657 | white | 23.5 | 28 | 0.691895 | 0.637939 | 2 | 1 | 0 | no | 0.7 | 0.5 | no dnr | 14 | 96 | 10.199219 | 102 | 40 | 39.19531 | 164.4375 | 3.599609 | 0.799927 | 1.299805 | 142 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 1.665527 |
8,352 | 58.55197 | 1 | male | 0 | 5 | 74 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 3,079 | 1,990.9004 | 1,955.76953 | 11 | white | 22.097656 | 38 | 0.75293 | 0.494995 | 1 | 0 | 0 | metastatic | 0.25 | 0.05 | no dnr | 5 | 115 | 5.799805 | 124 | 20 | 36.59375 | null | 3.299805 | 16.796875 | 1.099854 | 135 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 1.841553 |
8,353 | 64.24396 | 0 | male | 0 | 6 | 1,390 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 4,388 | 2,943.1934 | 2,494.30859 | 9 | white | 22.097656 | 33 | 0.840942 | 0.73999 | 1 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 6 | 72 | 7.099609 | 48 | 20 | 35.69531 | 323.75 | null | null | 1.699951 | 136 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,354 | 57.36099 | 0 | female | 0 | 11 | 1,390 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 16,935 | null | null | 13 | white | 24.097656 | 38 | 0.85498 | 0.761963 | 1 | 0 | 0 | no | 0.6 | 0.6 | dnr after sadm | 10 | 66 | 11.099609 | 114 | 36 | 39.59375 | 192.5625 | 2.699707 | 1.5 | 1 | 135 | 7.40918 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
8,355 | 50.18997 | 1 | male | 0 | 6 | 100 | Lung Cancer | Cancer | 4 | 12 | >$50k | 0 | 3,883 | 2,523.0332 | 2,455.57812 | 9 | white | 22.296875 | 18 | 0.630981 | 0.31897 | 1 | 1 | 0 | metastatic | 0.2 | 0.05 | dnr after sadm | 1 | 77 | 10.398438 | 70 | 20 | 35.69531 | null | 3.299805 | 0.199982 | 0.599976 | 132 | null | null | null | null | 2 | 2 | no(M2 and SIP pres) | 2 |
8,356 | 62.37399 | 0 | female | 0 | 6 | 1,388 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 5,885 | 3,970.6641 | 4,407.62891 | 16 | white | 19.597656 | 23 | 0.879883 | 0.799927 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 6 | 83 | 8.5 | 101 | 20 | 36.79688 | 180.9375 | 4.299805 | 0.5 | 0.699951 | 127 | 7.449219 | null | null | null | null | null | null | 2.464356 |
8,357 | 79.07697 | 1 | male | 0 | 6 | 828 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 4,192 | 2,770.7383 | 2,595.36914 | 7 | white | 22.398438 | 53 | 0.75 | 0.60498 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 6 | 121 | 5.699219 | 215 | 28 | 36.19531 | 219.03125 | null | null | 1.199951 | 143 | 7.349609 | null | null | null | null | null | no(M2 and SIP pres) | 2.876953 |
8,358 | 70.48596 | 0 | female | 0 | 23 | 1,385 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $11-$25k | 0 | 28,320 | 18,725.5 | 18,765.2656 | 18.666656 | white | 37 | 41 | 0.477966 | 0.359985 | 2 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 23 | 65 | 18.597656 | 146 | 38 | 39.39844 | 104.07812 | 2.699707 | 1.5 | 0.5 | 130 | 7.359375 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.195313 |
8,359 | 71.91498 | 1 | male | 0 | 9 | 650 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 17 | $25-$50k | 0 | 5,357 | 3,685.5586 | 3,325.11914 | 9 | white | 15.798828 | 16 | 0.78894 | 0.660889 | 1 | 0 | 0 | no | 0.9 | 0.95 | no dnr | 9 | 95 | 6.899414 | 64 | 24 | 36.69531 | null | 3 | 1.599854 | 1.199951 | 145 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,360 | 68.35596 | 1 | male | 0 | 24 | 841 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | under $11k | 61 | 56,732 | 37,232.125 | 39,466.4375 | 30.666656 | white | 35.09375 | 69 | 0.18399 | 0.095993 | 6 | 0 | 0 | no | 0.08 | 0.000512 | dnr after sadm | 10 | 113 | 26.699219 | 64 | 28 | 38.19531 | 132 | 2.199707 | 10.798828 | 3 | 141 | 7.429688 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,361 | 64.06598 | 0 | male | 0 | 16 | 1,377 | Lung Cancer | Cancer | 2 | 8 | $11-$25k | 0 | 21,757 | 13,109.3281 | 14,360.9375 | 21.666656 | white | 10.298828 | 25 | 0.819946 | 0.610962 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 16 | 64 | 8 | 76 | 10 | 38.09375 | 276.1875 | 4 | 0.299988 | 0.699951 | 133 | 7.40918 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
8,362 | 70.37097 | 1 | female | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 98,681 | 67,149.75 | 74,074.8125 | 43 | white | 27.796875 | 51 | 0.656982 | 0.55896 | 8 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 42 | 65 | 22.398438 | 72 | 40 | 37.69531 | 100 | 1.699951 | 0.299988 | 0.699951 | 131 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,363 | 75.52594 | 1 | male | 1 | 9 | 9 | Coma | Coma | 1 | 10 | >$50k | 44 | 79,205 | 53,814.1875 | 50,481.6562 | 36.5 | white | 21.398438 | 41 | 0.338989 | 0.265991 | 18 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 8 | 75 | 32.796875 | 68 | 12 | 39.19531 | 204 | 2.299805 | 1.199951 | 1.899902 | 141 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,364 | 61.51398 | 1 | male | 0 | 7 | 107 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 8,858 | 5,507.6953 | 5,136.6875 | 13 | white | 13.398438 | 19 | 0.779907 | 0.540894 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 1 | 75 | null | 77 | 22 | 37.79688 | null | null | null | 1.399902 | 139 | null | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,365 | 51.87698 | 1 | male | 0 | 15 | 1,228 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 12,740 | 8,003.8203 | 10,091.0625 | 13.666664 | white | 19.597656 | 33 | 0.897949 | 0.828979 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 15 | 79 | 10.599609 | 98 | 24 | 35.59375 | 361.875 | 4 | 1.399902 | 1.699951 | 135 | 7.459961 | null | null | null | null | 0 | null | 0 |
8,366 | 40.93597 | 0 | female | 0 | 10 | 1,371 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 9,355 | 6,916.2422 | 5,496.94922 | 9 | white | 34.5 | 53 | 0.72998 | 0.646973 | 1 | 1 | 0 | no | 1 | 0.9 | no dnr | 10 | 109 | 12.898438 | 108 | 22 | 37.69531 | 93.875 | null | 0.199982 | 7.299805 | 129 | 7.349609 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,367 | 52.93597 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | >$50k | 0 | 37,033 | 24,434.8125 | 21,937.4375 | 45.5 | white | 53.59375 | 88 | 0.153992 | 0.074997 | 1 | 1 | 0 | no | null | null | dnr after sadm | 8 | 39 | 16.898438 | 154 | 28 | 39.29688 | 102.84375 | 2.5 | 4.199219 | 3.399902 | 144 | 7.379883 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
8,368 | 77.23999 | 1 | male | 0 | 17 | 168 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 6 | $11-$25k | 0 | 19,734 | 14,627.5234 | 11,903.375 | 15.333328 | white | 27.898438 | 50 | 0.668945 | 0.572998 | 2 | 1 | 0 | no | 0.05 | 0.000125 | no dnr | 17 | 63 | 13.5 | 124 | 28 | 37.59375 | null | 4 | 0.5 | 2.799805 | 147 | null | null | null | null | null | null | no(M2 and SIP pres) | 4.344727 |
8,369 | 74.04498 | 1 | male | 0 | 26 | 33 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 75,250 | 48,129.75 | 52,292.5312 | 21.75 | white | 22.597656 | 24 | 0.618896 | 0.513916 | 23 | 0 | 0 | yes | 0.2 | 0.008 | dnr after sadm | 25 | 105 | 5.199219 | 104 | 36 | 36.59375 | 352.5 | null | null | 1.399902 | 141 | 7.769531 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
8,370 | 78.33496 | 1 | male | 0 | 14 | 267 | COPD | COPD/CHF/Cirrhosis | 3 | 5 | $11-$25k | 0 | 20,412 | 13,551.75 | 13,804.8281 | 21 | white | 23.296875 | 47 | 0.73999 | 0.591919 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 1 | 120 | 13.898438 | 59 | 33 | 37.79688 | 180 | 3.799805 | 0.899902 | 2.199707 | 134 | 7.299805 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,371 | 48.63797 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | $25-$50k | 100 | 11,142 | 7,791.1289 | 7,995.87891 | 63 | white | 50.796875 | 70 | 0.003 | 0 | 1 | 1 | 0 | no | null | null | dnr after sadm | 3 | 42 | 15.699219 | 68 | 35 | 34.19531 | 110.20312 | 2 | 1.899902 | 2.599609 | 154 | 7.539062 | null | null | null | null | null | <2 mo. follow-up | 4.214844 |
8,372 | 74.52197 | 1 | male | 0 | 7 | 794 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | under $11k | 9 | 4,039 | 2,678.4492 | 3,494.80859 | 7 | white | 14.898438 | 18 | 0.858887 | 0.767944 | 1 | 0 | 0 | no | 0.9 | 0.9 | dnr after sadm | 1 | 79 | 8.298828 | 73 | 24 | 35.89844 | 186.65625 | 4.099609 | 0.399963 | 0.699951 | 140 | 7.389648 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,373 | 29.97899 | 0 | male | 0 | 73 | 1,362 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 9 | 123,456 | 92,438 | 91,346.0625 | 16.5 | white | 20.796875 | 23 | 0.841919 | 0.787964 | 20 | 0 | 0 | yes | 0.75 | 0.7 | no dnr | 73 | 77 | 14.5 | 126 | 30 | 37.79688 | 240 | 2.599609 | 0.399963 | 0.899902 | 141 | 7.389648 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,374 | 52.02197 | 0 | female | 0 | 10 | 1,361 | Colon Cancer | Cancer | 1 | null | null | 0 | 15,758 | 10,225.4141 | 10,733.2656 | 22.5 | white | 17.796875 | 21 | 0.828979 | 0.628906 | 1 | 0 | 0 | metastatic | 1 | 0.1 | no dnr | 10 | 113 | 10 | 70 | 10 | 35.79688 | 282 | null | null | 0.799927 | 135 | 7.479492 | null | null | null | null | null | null | 2.312988 |
8,375 | 71.00598 | 1 | female | 0 | 6 | 28 | CHF | COPD/CHF/Cirrhosis | 2 | 17 | under $11k | 0 | 3,023 | 2,051.9375 | 1,920.01953 | 6 | white | 45 | 52 | 0.272949 | 0.103989 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 6 | 29 | 5.799805 | 59 | 24 | 37 | null | 3.099609 | 0.599976 | 5 | 132 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
8,376 | 63.918 | 1 | male | 0 | 40 | 65 | Coma | Coma | 4 | null | null | 61 | 60,050 | 77,295.875 | 85,570.625 | 36.5 | white | 23.199219 | 27 | 0.440979 | 0.366943 | 1 | 1 | 0 | no | 0.95 | 0.8 | dnr after sadm | 3 | 61 | 17.597656 | 78 | 6 | 37.89844 | 94.28125 | 2.799805 | 1.699951 | 1.199951 | 139 | 7.579102 | null | null | null | null | null | null | 2.715332 |
8,377 | 79.31799 | 1 | male | 0 | 4 | 14 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 6 | null | 44 | 10,346 | 6,697.7539 | 10,274.2031 | 21 | white | 28.296875 | 75 | 0.212982 | 0.066986 | 1 | 0 | 1 | no | null | null | dnr after sadm | 1 | 57 | 5.299805 | 112 | 36 | 39.59375 | 485.6875 | 1.699951 | 2.699707 | 2.099609 | 148 | 7.469727 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
8,378 | 75.58698 | 1 | female | 0 | 5 | 809 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | $11-$25k | 0 | 2,641 | 1,807.6631 | 1,603.5293 | 11 | white | 17.699219 | 32 | 0.855957 | 0.762939 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 75 | 8.898438 | 70 | 20 | 35.69531 | null | 3.699707 | 1.899902 | 1.5 | 136 | null | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
8,379 | 65.875 | 0 | male | 0 | 5 | 1,350 | Lung Cancer | Cancer | 2 | 11 | under $11k | 0 | 5,483 | 3,792.6484 | 3,592.72852 | 10 | white | 24.699219 | 28 | 0.522949 | 0.200989 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | no dnr | 5 | 71 | 22.898438 | 67 | 26 | 35.09375 | null | 3.799805 | 0.5 | 0.899902 | 124 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.420898 |
8,380 | 60.53897 | 1 | female | 1 | 3 | 3 | Coma | Coma | 1 | null | null | 0 | 42,868 | 27,519.3594 | 26,107.1094 | 59 | null | 46 | 66 | 0.084991 | 0.048996 | 6 | 0 | 0 | no | null | null | no dnr | 3 | 43 | 17.699219 | 140 | 12 | 38.69531 | 132.71875 | null | null | 5.299805 | 130 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
8,381 | 72.34998 | 0 | male | 0 | 42 | 1,349 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 100 | 112,532 | 79,493.25 | 77,019.1875 | 29.75 | white | 21.097656 | 41 | 0.327942 | 0.212982 | 13 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 42 | 69 | 10.199219 | 78 | 40 | 39.89844 | 240 | null | null | 1.699951 | 146 | 7.469727 | null | null | null | null | 0 | null | 0 |
8,382 | 78.80396 | 1 | male | 0 | 9 | 258 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 4,893 | 3,245.4336 | 3,003.36914 | 10.5 | white | 21 | 24 | 0.638916 | 0.458984 | 1 | 0 | 0 | no | 0.95 | 0.8 | dnr after sadm | 1 | 97 | 4.5 | 74 | 16 | 35.19531 | null | 3.599609 | 0.699951 | 1.799805 | 133 | null | null | null | null | 2 | 2 | no(M2 and SIP pres) | 2 |
8,383 | 87.70398 | 1 | male | 0 | 14 | 380 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 9,576 | 6,121.2734 | 5,868 | 13 | white | 16.398438 | 42 | 0.738892 | 0.589966 | 1 | 0 | 0 | yes | 0.6 | 0.5 | dnr after sadm | 1 | 103 | 6.399414 | 96 | 28 | 38 | 204.75 | 3.799805 | 1.099854 | 1.5 | 139 | 7.379883 | null | null | null | null | null | null | 4.556641 |
8,384 | 54.52197 | 1 | male | 0 | 20 | 137 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 81,712 | 49,968.125 | 51,202.75 | 21.333328 | white | 24.296875 | 24 | 0.717896 | 0.631958 | 38 | 0 | 0 | yes | 0.5 | 0.2 | no dnr | 20 | 75 | 4.899414 | 126 | 28 | 36.29688 | 346.9375 | null | null | 1.099854 | 140 | 7.439453 | null | null | null | null | 5 | null | 5 |
8,385 | 75.30194 | 1 | male | 0 | 8 | 632 | Colon Cancer | Cancer | 2 | 8 | $11-$25k | 0 | 11,949 | 7,253.4805 | 7,676.88672 | 17 | white | 16.296875 | 24 | 0.807983 | 0.589966 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 8 | 73 | 5.399414 | 96 | 24 | 38.09375 | null | null | null | 1.299805 | 132 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,386 | 65.17499 | 0 | male | 0 | 28 | 1,347 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 26 | 31,065 | 19,741.4375 | 19,872.3594 | 17 | white | 26 | 39 | 0.707886 | 0.547974 | 1 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 1 | 79 | 7.899414 | 103 | 36 | 37.89844 | 185.6875 | 2.399902 | 0.599976 | 1 | 138 | 7.469727 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
8,387 | 22.88799 | 1 | male | 0 | 40 | 604 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 0 | 54,848 | 37,453.5625 | 39,282.1562 | 27 | white | 35.195313 | 62 | 0.730957 | 0.647949 | 10 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 40 | 63 | 21.796875 | 140 | 50 | 36.09375 | 182.84375 | 2 | 3.5 | 0.399963 | 137 | 7.449219 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
8,388 | 61.30899 | 1 | male | 0 | 31 | 730 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 135,370 | 82,462.5 | 88,001.9375 | 21.5 | white | 29.199219 | 36 | 0.572998 | 0.462952 | 28 | 0 | 0 | yes | null | null | no dnr | 31 | 116 | 0.099991 | 112 | 24 | 36.19531 | 353 | null | null | 1.199951 | 135 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,389 | 62.073 | 1 | male | 0 | 11 | 68 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 6,530 | 4,838.1602 | 5,611.51953 | 2 | white | 4.399414 | 20 | 0.886963 | 0.74292 | 1 | 0 | 0 | metastatic | null | null | no dnr | 11 | 115 | 14.699219 | 73 | 24 | 36.29688 | 357.125 | 4.599609 | 0.399963 | 1.199951 | 134 | 7.459961 | null | null | null | null | null | no(M2 and SIP pres) | 2.161133 |
8,390 | 63.22198 | 1 | male | 0 | 5 | 632 | Lung Cancer | Cancer | 1 | null | null | 0 | 6,315 | null | null | 7 | white | 14.5 | 17 | 0.757935 | 0.50293 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 5 | 75 | 6.699219 | 83 | 18 | 36.39844 | null | null | null | 1.099854 | 136 | null | null | null | null | null | null | null | 1.941162 |
8,391 | 81.21594 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 18,554 | 13,085.6641 | 13,771.9297 | 32 | white | 25.898438 | 42 | 0.578979 | 0.468994 | 4 | 0 | 0 | yes | null | null | dnr after sadm | 4 | 59 | 77.390625 | 58 | 30 | 36.79688 | 155.09375 | null | null | 1.5 | 138 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,392 | 68.43799 | 0 | male | 0 | 9 | 1,335 | Colon Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 12,932 | 7,977.168 | 7,868.26953 | 19 | white | 18.199219 | 23 | 0.793945 | 0.563965 | 1 | 1 | 0 | metastatic | 0.98 | 0.8 | no dnr | 9 | 113 | 12.599609 | 76 | 16 | 36.19531 | null | null | null | 1.599854 | 137 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
8,393 | 59.53198 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 9,529 | 6,561.9961 | 6,822.88672 | 29 | white | 37.296875 | 77 | 0.242981 | 0.140991 | 2 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 5 | 61 | 9.699219 | 120 | 28 | 36.39844 | 207.5 | 1.699951 | 15.5 | 4.099609 | 135 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,394 | 76.70599 | 1 | male | 0 | 17 | 18 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 44 | 46,129 | 29,804.6719 | 32,551.4844 | 38.333313 | white | 31 | 44 | 0.337952 | 0.15097 | 2 | 0 | 0 | no | null | null | dnr after sadm | 15 | 70 | 15.898438 | 116 | 40 | 38.29688 | 215 | 1.799805 | 0.299988 | 1 | 140 | 7.389648 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
8,395 | 73.26996 | 0 | female | 0 | 46 | 1,335 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 26 | 65,771 | 44,039.9375 | 44,007.4688 | 27 | white | 27.699219 | 41 | 0.590942 | 0.398987 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 30 | 55 | 7.299805 | 71 | 8 | 37.59375 | 187.5 | 2.799805 | 0.899902 | 2.5 | 142 | 7.669922 | null | null | null | null | null | null | 3.068359 |
8,396 | 53.66199 | 1 | male | 0 | 5 | 90 | Lung Cancer | Cancer | 1 | 11 | null | 26 | 5,210 | 3,389.5176 | 3,521.0293 | 12 | white | 24.597656 | 8 | 0.435974 | 0.127991 | 1 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 1 | 104 | 3.399902 | 69 | 24 | 37 | 344.4375 | 2.599609 | 0.399963 | 0.699951 | 142 | 7.40918 | null | null | null | null | null | no(M2 and SIP pres) | 2.515137 |
8,397 | 81.62598 | 1 | male | 0 | 7 | 180 | COPD | COPD/CHF/Cirrhosis | 5 | 7 | null | 9 | 4,685 | 3,020.8144 | 3,273.85938 | 18 | white | 15.599609 | 36 | 0.768921 | 0.632935 | 1 | 0 | 1 | yes | 0.5 | 0.5 | no dnr | 7 | 74 | 4.899414 | 81 | 24 | 36.09375 | 233.3125 | null | null | 0.899902 | 145 | 7.379883 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
8,398 | 43.63898 | 1 | male | 0 | 35 | 39 | Coma | Coma | 0 | 12 | $25-$50k | 100 | 22,306 | 27,158.3594 | 28,949.3125 | 22.75 | white | 23.5 | 23 | 0.438965 | 0.365967 | 1 | 0 | 0 | no | null | null | dnr after sadm | 11 | 114 | 25.796875 | 74 | 34 | 36.09375 | 445 | 2.699707 | 0.899902 | 0.699951 | 129 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
8,399 | 69.47797 | 0 | female | 0 | 15 | 1,329 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $25-$50k | 0 | 11,658 | 7,918.2812 | 7,724.65625 | 12 | white | 17 | 20 | 0.878906 | 0.79895 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 15 | 65 | null | 63 | 20 | 36 | null | null | null | 1.199951 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,400 | 76.96594 | 1 | male | 0 | 51 | 85 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 158,804 | 111,121.562 | 106,241.5 | 30 | white | 18.898438 | 32 | 0.620972 | 0.515991 | 30 | 0 | 0 | yes | null | null | dnr after sadm | 16 | 79 | 11.699219 | 80 | 40 | 38.69531 | 223.3125 | null | null | 1.399902 | 146 | 7.439453 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.